A detailed history of Royal Bank Of Canada transactions in Profound Medical Corp. stock. As of the latest transaction made, Royal Bank Of Canada holds 401,325 shares of PROF stock, worth $3.02 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
401,325
Previous 401,229 0.02%
Holding current value
$3.02 Million
Previous $3.37 Million 5.11%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$7.47 - $11.18 $717 - $1,073
96 Added 0.02%
401,325 $3.19 Million
Q2 2024

Aug 14, 2024

BUY
$7.25 - $9.07 $7,996 - $10,004
1,103 Added 0.28%
401,229 $3.37 Million
Q1 2024

Nov 05, 2024

SELL
$7.3 - $9.46 $8,051 - $10,434
-1,103 Reduced 0.27%
400,126 $3.41 Million
Q1 2024

May 15, 2024

SELL
$7.3 - $9.46 $240 - $312
-33 Reduced 0.01%
400,126 $3.41 Million
Q4 2023

Feb 14, 2024

SELL
$7.85 - $11.18 $13,140 - $18,715
-1,674 Reduced 0.42%
400,159 $3.4 Million
Q3 2023

Nov 14, 2023

BUY
$7.91 - $13.27 $9,120 - $15,300
1,153 Added 0.29%
401,833 $4.1 Million
Q2 2023

Aug 14, 2023

SELL
$9.27 - $14.88 $2,910 - $4,672
-314 Reduced 0.08%
400,680 $5.21 Million
Q1 2023

May 15, 2023

BUY
$8.85 - $13.27 $12,159 - $18,232
1,374 Added 0.34%
400,994 $3.73 Million
Q4 2022

Feb 14, 2023

BUY
$3.18 - $10.91 $41,340 - $141,830
13,000 Added 3.36%
399,620 $4.35 Million
Q3 2022

Nov 14, 2022

SELL
$3.99 - $9.3 $1,540 - $3,589
-386 Reduced 0.1%
386,620 $1.56 Million
Q2 2022

Aug 15, 2022

BUY
$6.34 - $9.53 $414,033 - $622,356
65,305 Added 20.3%
387,006 $2.82 Million
Q1 2022

May 16, 2022

BUY
$8.16 - $11.33 $489,583 - $679,777
59,998 Added 22.93%
321,701 $2.9 Million
Q4 2021

Feb 14, 2022

BUY
$10.38 - $15.2 $92,662 - $135,690
8,927 Added 3.53%
261,703 $2.94 Million
Q3 2021

Nov 15, 2021

BUY
$13.6 - $17.88 $11,505 - $15,126
846 Added 0.34%
252,776 $3.7 Million
Q2 2021

Aug 16, 2021

BUY
$16.0 - $20.59 $4.03 Million - $5.19 Million
251,930 New
251,930 $4.12 Million

Others Institutions Holding PROF

About Profound Medical Corp.


  • Ticker PROF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 20,851,300
  • Market Cap $157M
  • Description
  • Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...
More about PROF
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.